Search Results - Expert Opinion Videos

Search results within Expert Opinion Videos for: abuse
Can opioids be rationally prescribed for chronic pain? Dr. Stacey considers some of the components of getting there, including strengths and limitations in the current CDC guidelines, the practice of tapering; elements of patient assessment, red flags to watch for, and the proper role of opioids in the multimodal treatment ...
A specialist in public policy and bioethics considers the conundrum of gaining insurance coverage for this cost-efficient but expensive paradigm change to prescribing decisions, as well as some of the ethical issues associated with the practice of pharmacogenomic testing. ...
Dr. Stanos reviews the development of evidence based medicine and offers some pointers to primary practitioners on how to intelligently assess guidelines and clinical trials. Critical evaluation can help clinicians become better users of clinical and research information. ...
The recently released CDC prescribing guidelines and recommendations from the National Pain Strategy refer to pain psychology as on the critical path to the management of pain. Drs. Mackey and Darnall discuss this role and what needs to be done to bring this treatment modality within the reach of patients ...
Opioid induced respiratory depression is associated with over 16,000 deaths in the US each year, and the risks of opioid therapy are not fully understood by many prescribers. Dr. Fudin reviews some of the unanticipated concerns, with a focus on assessing and managing risk for respiratory depression. ...
Morphine equivalent daily dose (MEDD) has been routinely used in clinical practice and as a research variable. Dr. Schatman discusses some of the ethical concerns attending the use of this flawed concept, for both clinical guidance and research validity. ...
Concern over opioid abuse is amplifying interest in opioid induced hyperalgesia among governing bodies and payor organizations. Dr. Harden discusses the current state of the science surrounding OIH, including terminology, technology/methodology, and existing evidence. Additionally, he offers some observations on the 2016 CDC prescribing guidelines for primary care practitioners. ...
At PAINWeek 2016, a panel of medical, legal, and pharmacy specialists convened to offer their views on the recently introduced prescribing guidelines for chronic pain from the CDC. In this segment, Dr. Ziegler and Dr. Fudin summarize some of the concerns voiced over the guideline development process, and the utility ...
The challenges of acute pain management and addiction progression can be met. Debra B. Gordon, RN, DNP, FAAN, gives some pointers. ...
It's important for practitioners to be "in the know" about drugs of abuse, whether new ones, or new abuses of well-known drugs. ...
One approach to maintaining the balance between risks and benefits of opioid therapy for chronic pain has been the development of abuse deterrent formulations. A pain management PA provides an overview of abuse deterrent technologies, both existing and emerging.While developments are encouraging, they are but one part of the solution. ...
Special K is often thought of as a drug of abuse, but it also may be a valid opioid replacement. ...
A specialist in addiction medicine offers guidance in identifying opioid misuse and the appropriate means of withdrawing patients from long term opioid therapy. The longer term management and rehabilitation of these patients is also considered. ...
In this segment, a former law enforcement professional and credentialed pharmacist considers the world of illicit pharmaceutical trafficking from the juncture of prescribers, investigators, and the legal system. What is happening, and how can the... ...
Most workers compensation claims involve pain treatment, and most of that therapy involves pharmaceuticals. Dr. Foster overviews the trends and treatment guidelines that primary care practitioners should be aware of, to achieve the best outcomes for... ...
In response to the escalating crisis of opioid abuse and overdose fatalities, states are adopting dosage thresholds as part of their prescribing guidelines. A clinical pharmacist and public policy professor summarize the public health landscape that... ...
Prescription Drug Monitoring Programs (PDMPs) are widely available, but not yet uniformly used. A clinical pharmacist and associate professor evaluates the current landscape, and what can be improved to enhance their utility in curbing substance... ...
High-quality research on the safety and efficacy of medical cannabinoids as pain therapy has long been impeded by an adverse regulatory environment. Even as the prominence of medical marijuana continues to grow--in part due to the public health... ...
Although prescription medications are of great benefit to many patients with chronic non-cancer pain, there are significant complications for patients who are either addicted or in recovery. Dr. Durham, a clinical pharmacist, professor of pharmacy,... ...
Must opioid therapy work for everyone to be a valid part of the treatment armamentarium? Dr. Passik considers some of the consequences of "absolutist thinking" that are leading members of the pain community to unnecessarily harsh self-judgements.... ...
A specialist in pain and substance abuse discusses findings from the research on vulnerable populations in the pain community. Patients with pain and concurrent substance use disorders are particularly at risk for depression and suicidal ideation. To... ...
The enforcement arms of both commercial and government payor plans are focused on reimbursement claims for clinical laboratory services. Ongoing changes to billing and coding for services further complicate the picture for practitioners. Here's... ...
A panel of legal and compliance experts discuss some of the issues confronting prescribers of controlled substances in the management of patients who may be abusing and/or diverting their medications. How should clinicians negotiate the terrain... ...
Dr. Zacharoff sketches the background history of Prescription Drug Monitoring Programs, and offers an assessment of how well they are performing and how they can be improved. Watch the segment for recommendations on what you need to know to... ...
Dr. Argoff comments on the appropriate role of opioid analgesics as part of therapy for chronic noncancer pain, with observations on protecting legitimate access while preventing abuse. ...
Dr. Argoff comments on the appropriate role of opioid analgesics as part of therapy for chronic noncancer pain, with observations on protecting legitimate access while preventing abuse. ...
Observations by a pain management educator and lawyer on some key issues for pain medication prescribers. ...
Observations on the clinical condition of coping, and a discussion of some motivational strategies that may be beneficial to patient and clinicians in addressing the phenomenon. ...
Observations on the clinical condition of coping, and a discussion of some motivational strategies that may be beneficial to patient and clinicians in addressing the phenomenon. ...
Observations by a pain management educator and lawyer on some key issues for pain medication prescribers. ...
An in-depth, 4- part examination of opioid risk assessment in the primary care setting; the need, the tools; the clinician responsibilities. ...
An in-depth, 4- part examination of opioid risk assessment in the primary care setting; the need, the tools; the clinician responsibilities. ...
An in-depth, 4- part examination of opioid risk assessment in the primary care setting; the need, the tools; the clinician responsibilities. ...
An in-depth, 4- part examination of opioid risk assessment in the primary care setting; the need, the tools; the clinician responsibilities. ...
Dr. Passik comments on the debate over opioids as appropriate for chronic non-cancer pain, identifying some shortcomings in the arguments from both sides. ...